A recent study has found that 7 hours and 18 minutes may be the optimal amount of sleep you need each night to lower your ...

Sleeping for 7 hours and 18 minutes every night may be the sweet spot for warding off the risk of insulin resistance—the ...

The most recent version of NG28, the National Institute for Health and Care Excellence's (NICE) guidelines for managing type 2 diabetes in adults, has been released on February 18, 2026.

Sustained GLP-1 receptor agonist therapy is linked to greater improvements in A1c levels than DPP-4 inhibitor therapy in patients with type 2 diabetes, a Danish real-world analysis shows.

Jardiance (empagliflozin) is a medicine for type 2 diabetes approved by the FDA in 2014. It is approved to help lower blood sugar levels in adults and children with type 2 diabetes and to lower the ...

New research suggests that just over 7 hours of nightly sleep is ideal for preventing insulin resistance, a precursor to type 2 diabetes.

A large study of US veterans suggests that diabetes and weight-loss medicines may curb cravings and lower severe addiction outcomes, though clinical trials are still needed.

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).

Eli Lilly and Company has reported detailed findings from the ACHIEVE-3 Phase III trial comparing the efficacy and safety of ...

Experts explain how it may be wreaking havoc on your health.